American Society of Transplantation/Juvenile Diabetes Research Foundation Faculty Grant (For diabetes-related applications)
American Society of Transplantation/Juvenile Diabetes Research Foundation
All Regions
$80,000

American Society of Transplantation/Juvenile Diabetes Research Foundation Faculty Grant (For diabetes-related applications)

This is a two-year grant ($40,000/year) for Junior Faculty (basic or clinical science).

This grant is co-sponsored by AST and Juvenile Diabetes Research Foundation International (JDRF) to specifically support research targeted to the application of transplantation to the understanding and treatment of juvenile onset (i.e., type I) diabetes mellitus (e.g., the studies of islet transplantation, autoimmunity, etc.).

Appropriate applications in the general pool of the AST Faculty Grants will be considered for the AST/JDRF Grant if no Fellowship Grant applications of sufficiently high quality are reviewed.

To be considered for the AST/JDRF Grant, individuals applying for the AST Basic Science or Clinical science grants, whose proposal pertains to diabetes should check the appropriate box on the front page of the application. Checking this box will ensure that the application is considered for this additional grant which will increase chances for funding.

The highest scoring grant application in the general pool of Fellowship Grants that pertains to diabetes will be selected for this grant.

Funding of this grant will be dependent upon the budgetary constraints of the two co-sponsoring organizations. The application, review and funding process for the general pool of the AST Faculty Grants will apply to this specialty grant.

IMPORTANT DISCLAIMER: The AST will not assume responsibility for any clinical study funded by the AST Awards and Grants Program. Such proposals must be IRB-approved. Any responsibility will be assumed by the P.I. and the funded institution.

Application deadline: Midnight Eastern Time on Friday, November 21, 2008.

American Society of Transplantation
15000 Commerce Parkway
Suite C
Mt.Laurel, NJ,08054

Phone: 856.439.9986
Fax: 856.439.9982

Email: ast@ahint.com

Endocrinologist, Junior Faculty, Junior Investigator, Junior Researcher, Junior Scientist, Physician Researcher
American Federation for Aging Research Research Grants
American Federation for Aging Research
All Regions
12/16/2008
$75,000

The 2009 AFAR Research Grants

The Program
The major goal of this program is to assist in the development of the careers of junior investigators committed to pursuing careers in the field of aging research. AFAR supports research projects concerned with understanding the basic mechanisms of aging. Projects investigating age-related diseases are also supported, especially if approached from the point of view of how basic aging processes may lead to these outcomes. Projects concerning mechanisms underlying common geriatric functional disorders are also encouraged, as long as these include connections to fundamental problems in the biology of aging. Projects that deal strictly with clinical problems such as the diagnosis and treatment of disease, health outcomes, or the social context of aging are not eligible.

Examples of promising areas of research include:
Aging and immune function
Genetic Control of longevity
Neurobiology and neuropathology of aging*
Invertebrate or vertebrate animal models
Cardiovascular aging
Aging and cellular stress resistance
Metabolic and endocrine changes
Age-related changes in cell proliferation
Caloric restriction and aging
DNA repair and control of gene expression
Biology of the menopause
Aging and apoptosis
Biodemographic analysis of aging
Comparative gerontology
Evolutionary biological aspects of the biology of aging
*Applicants proposing a project in Alzheimer's Disease research, should apply for the Rosalinde and Arthur Gilbert Foundation/AFAR New Investigator Awards in Alzheimer's Disease. (This program is currently under review for renewal in 2009.)

It is anticipated that approximately 15 grants of up to $75,000 each will be awarded in 2009. Applicants may propose to use the award over the course of one or two years as justified by the proposed research. Funds may not be requested for overhead or indirect costs. Funding will begin July 1, 2009.

Recipients of this award are expected to attend the AFAR Grantee Conference. The purpose of the meeting is to promote scientific and personal exchanges among recent AFAR grantees and experts in aging research.

Eligibility

The applicant must be an independent investigator with assigned independent space and must be within the first four years of a junior faculty appointment (instructor, assistant professor or equivalent) by July 1, 2009.

The AFAR Research Grant Program does not provide support for:
Postdoctoral fellows in the laboratory of a senior investigator
Investigators who have already received major extramural funding for research on aging (such as an R01 grant)
Senior faculty, i.e. at the rank of Associate Professor level or higher
Former AFAR Research Grant recipients
NIH Intramural program employees
Applicants for the 2009 Glenn/AFAR Breakthrough in Gerontology (BIG) award
Application Guidelines

Four criteria are used to determine the merit of an application:

Qualifications of the applicant;
Quality of the proposed research;
Excellence of the research environment;
Likelihood that the project will advance the applicant's career in aging research.
If you are using animals in your research, please review Principles of Animal Use for Gerontological Research.

Application Procedures

All candidates must submit applications endorsed by their institution (only not-for-profit settings in the United States.) The deadline for receipt of all applications and supporting materials is December 16, 2008 at 5:00 p.m. EST. Please refer to the AFAR instruction sheet and application for complete application procedures. Incomplete applications cannot be considered.

Applications are reviewed in two stages: The initial screening takes place in mid-April, after which candidates are advised of the status of their applications via email. A final decision about grant awards is made in early June. The award start date is July 1, 2009.

AFAR can provide critiques only for those applications that are reviewed, at the second stage, by their Review Committee.

Reporting Requirements

Investigators will be required to submit a brief narrative report on the progress of their research five months after the start date of the award. Final narrative and financial reports are required within three months following the end date of the award. 

American Federation for Aging Research (AFAR) | 55 West 39th Street, 16th Floor | New York, NY 10018
Phone: (212) 703-9977 | Toll-free: (888) 582-2327 | Fax: (212) 997-0330
E-mail: grants@afar.org or info@afar.org

Biostatiscian, Cell Biologist, Geriatrician, Gerontologist, Junior Faculty, Junior Investigator, Junior Researcher, Junior Scientist, Molecular Biologist , Physician Researcher, Scientist, Young Investigator, Young Scientist, Cardiologist, Endocrinologist, Immunologist, Internist, Neuroscientist, Nutritionist, Physiologist
Request for Proposals for Building the Evidence: Problem Solving – Injections
American Association of Diabetes Educators
All Regions
11/03/2008
$40,000

American Association of Diabetes Educators Request for Proposals for Building the Evidence: Problem Solving – Injections

The AADE Education and Research Foundation is offering a $40,000 grant for a research project in the field of diabetes education. The Principal Investigator must be an AADE member at the time of application; team members can be from a variety of disciplines.

We are seeking proposals that address problem solving issues and potential solutions surrounding effective insulin/medication injection in patients with a BMI>35 or very low body fat. The overall aim is to identify best practices and effective problem solving solutions for populations who have difficulty with administration of their injections.

Proposals must be postmarked by the first business day of November (Monday, November 3, 2008)

Specific Aims
Currently, there is a lack of research on problem solving issues and potential solutions surrounding
effective insulin/medication injection in patients with a BMI>35 or very low body fat. The overall aim is to
identify best practices and effective problem solving solutions for populations who have difficulty with
administration of their injections. The proposed research must examine the problems that individuals at
both the high and low ends of the BMI Index face regarding injection of insulin or other diabetes
medication with a syringe or insulin pen. The findings will be sufficiently robust that they can be
disseminated to diabetes educators via a presentation and/or publication.
The Researcher will describe in detail the problem solving and injection intervention(s) that will be used,
which method of data collection and analysis will be appropriate for the study, suggested methods for
data collection and analysis follow. The proposed study should also address potential issues, such as
inability of patient to see the injection site due to excess abdominal fat and inability to locate an
appropriate injection site due to low body fat. Once the problems have been identified and documented,
the researchers should implement and evaluate one or more problem solving interventions.
Research questions
1. What are the knowledge, skills and problem solving behaviors that people with diabetes need to
effectively self-manage their injections?
2. What injection techniques should health care professionals use to educate patients to insure that either
obese (BMI >35), extremely thin (BMI <18.5 or extremely muscular) effectively inject insulin or other
diabetes medications once they leave the clinical setting?
3. What problem solving questions or activities can the CDE employ to ensure that the proper technique
is used and/or adjustments to technique are made for the target populations?
This proposal must address these research questions, specific research aims, and state the
intended objectives of the proposed study. Applicants must state the rationale for their
approach to the problem and state the hypothesis this research is designed to address.
Significance
Briefly describe the background information relevant to this proposal, including a brief evaluation
of the existing body of knowledge about the problem. Identify the importance of this study to the
field of diabetes education and/or diabetes nursing practice.

http://www.diabeteseducator.org/Foundation/Grants/CurrentGrants.html

Diabetes Educator, Nurse Researcher
Fanconi Anemia Research Fund Program Announcement: Head And Neck Carcinogenesis
Fanconi Anemia Research Fund
All Regions
12/31/2008
$0

Fanconi Anemia Research Fund Program Announcement:
Head And Neck Carcinogenesis 
 
Key Dates
Release Date: July 1, 2008
Application Submission Date: Ongoing
Peer Review Dates: Ongoing
Earliest Anticipated Start Date: Ongoing
Summary
Fanconi anemia is a rare hereditary disease characterized by bone marrow failure, developmental
anomalies, a high incidence of myelodysplasia (MDS) and acute non-lymphocytic leukemia (AML),
squamous cell carcinoma of the head and neck, and cellular hypersensitivity to cross linking agents.
The function of the proteins is largely unknown, but many of them form complexes with each other
and in one canonical “pathway” seven or eight of the known Fanconi anemia (FA) proteins bind
together in a nuclear complex, a complex apparently required for the monoubiquitination of two of
the three proteins not found in the core complex, FANCD2 and FANCI. Once this occurs,
FANCD2 and FANCI translocate to damage-induced nuclear foci containing BRCA1, BRCA2 and
Rad51. The functions of FANCD2 and FANCI in these nuclear complexes are unclear. Although
more than 90% of the research in this field focuses on mechanisms of genotoxicity, a goal of the
Fanconi Anemia Research Fund is to encourage investigative approaches dealing with the tissuespecific
issues of the FA phenotype.
Some have argued that because hypersensitivity to genotoxic stress is a feature of all somatic cells in
FA, tissue-specific outcomes (specific epithelial malignancies and bone marrow failure, for example)
are less likely to be related simply to genetic instability than to other functions of the protein. In fact,
multiple biochemical functions have been ascribed to some of the FA proteins and, in some cases,
these functions are cytoplasmic and not nuclear. The role of the Fanconi anemia proteins in
protecting normal individuals against sporadic head and neck cancers is entirely unknown.
The natural course of the disease in FA patients is unique. The onset of head and neck cancers in
patients with Fanconi anemia (age 18-40) is decades earlier than in non-FA patients with this type of
cancer and, unlike non-FA patients, the majority of such patients are neither tobacco smokers nor
alcohol drinkers. The management of FA patients with this malignancy is also challenging. For
example, FA patients may experience potentially lethal toxic effects from radiation and chemotherapy
doses conventionally prescribed to patients with head and neck cancers. Therefore, clinical
management is limited to surgical approaches and less-than-fully tested pharmacologic modalities
that do not lead to DNA damage.
This funding opportunity will use the investigator-initiated award mechanism to support work
focused on the molecular pathogenesis, diagnosis, and treatment of head and neck squamous cell
carcinoma in patients with FA. We expect that the nature and scope of the proposed research
will vary from application to application. We expect that the size and duration of each award will
also vary. The total amount awarded and the number of awards will depend upon the number,
quality, duration, and costs of the applications received.
Eligible Applications
The goal of this initiative is to foster studies on the molecular pathogenesis, diagnosis and
treatment of head and neck cancers in patients with Fanconi anemia. Applications focusing
primarily on hematopoietic malignancies, bone marrow failure, developmental anomalies,
endocrinopathies, or general functions of the FA proteins in DNA damage and repair responses
will not be accepted for review under this RFA.
Applications from the following will be considered:
􀂃 Eligible domestic and foreign institutions/organizations, including for-profit or nonprofit,
public or private, units of state and local governments, and eligible agencies of the
federal government.
􀂃 Eligible principal investigators include any individual with the skills, knowledge, and
resources necessary to carry out the proposed research.
􀂃 Applicants may submit only one application.
Content and Form of Application Submission
Applications must be prepared using the most current Fanconi Anemia Research Fund (Fund)
research grant application instructions and forms.

Fanconi Anemia Research Fund, Inc.
1801 Willamette Street, Suite 200
Eugene, OR 97401

Telephone: 541-687-4658
Family Support Toll-Free Line (in United States):
1-888-FANCONI (888-326-2664)
Fax: 541-687-0548
E-mail: info@fanconi.org

Cell Biologist, Molecular Biologist , Oncologist, Physician Researcher, Scientist, Hematologist
Medical Student Achievement Awards
Endocrine Society
All Regions
12/31/2008
$0
Medical Student Achievement Awards

Awarded to senior medical school students and osteopathic school students who have shown exceptional ability and interest in endocrinology. This program is designed to encourage outstanding students to pursue careers in endocrinology and related fields of medicine and basic science. Supported by The Endocrine Society.

This award provides the recipient with a one-year Fellow/Student Associate membership in the Society, free online access to all four Society journals through 2009, and an award certificate. The recipient will also be acknowledged on the Society’s Web site and in the annual Awards Brochure.

Because endocrinology is an integrative discipline spanning basic science and clinical medicine, it is taught in a variety of ways in different medical schools. Therefore, each school has the flexibility to establish its own selection process and criteria.

To nominate a student from your institution for the award, please refer to the list of participating institutions. A contact person has been established at most institutions as indicated on the list. Please contact that person directly to submit your nomination.

Nomination Deadline: December 31, 2008

Questions may be directed to awards@endo-society.org.
Medical Student, Osteopathic Medical Student
Career Development Award in Diabetes-Related research
American Diabetes Association
All Regions
01/15/2009
$750,000

Career Development Award
Award Description: The American Diabetes Association’s Career Development Awards are designed to assist outstanding Assistant Professor level faculty investigators in conducting diabetes-related research. The award supports an individual’s salary and research project to enable the investigator to advance his/her career as an independent investigator.
Support: Awards are $150,000 per year for up to five years, plus 15% allowable indirect costs. Additionally, applicants may request a $25,000 stipend for each of the first two years for additional equipment.
Deadline Dates: July 15, 2008 for January 1, 2009 funding and January 15, 2009 for July 1, 2009 funding.

Call the American Diabetes Association at 1-800-DIABETES (1-800-342-2383). Our hours of operation are Monday - Friday, 8:30 AM - 8 PM Eastern Standard Time.
Or write to us:
American Diabetes Association
ATTN: National Call Center
1701 North Beauregard Street
Alexandria, VA 22311

Endocrinologist, Junior Faculty, Junior Investigator, Junior Researcher, Junior Scientist, Medical School Faculty, New Investigator, Young Investigator, Young Scientist
Junior Faculty Award for Diabetes Research
American Diabetes Association
All Regions
01/15/2009
$360,000

Junior Faculty Award
Award Description: These awards support new investigators who are establishing their independence in diabetes research. Applicants can have any level of faculty appointment up through assistant professor.
Support: Awards are up to $120,000 per year for up to three years for direct costs, plus 15% allowable indirect costs. Additionally, applicants can request up to $10,000 per year towards the repayment of the principal on loans for a doctoral degree (MD, PhD, PharmD, DPM or DO). There is not a fixed limit for PI Salary.
Deadline Dates: July 15, 2008 for January 1, 2009 funding and January 15, 2009 for July 1, 2009 funding.

Call the American Diabetes Association at 1-800-DIABETES (1-800-342-2383). Our hours of operation are Monday - Friday, 8:30 AM - 8 PM Eastern Standard Time.
Or write to us:
American Diabetes Association
ATTN: National Call Center
1701 North Beauregard Street
Alexandria, VA 22311

Clinical Pharmacist, Endocrinologist, Junior Faculty, Junior Investigator, Junior Researcher, Junior Scientist, Medical School Faculty, New Investigator, Physician Researcher, Young Investigator, Young Scientist
American Diabetes Association (ADA)-Association of Subspecialty Professors (ASP) Young Investigator Innovation Award in Geriatric Endocrinology
American Diabetes Association (ADA)-Association of Subspecialty Professors (ASP)
All Regions
01/15/2009
$150,000

ADA-ASP Young Investigator Innovation Award in Geriatric Endocrinology
Award Description: The American Diabetes Association (ADA)-Association of Subspecialty Professors (ASP) Young Investigator Innovation Award in Geriatric Endocrinology provides grant support to new investigators. This program supports entry-level faculty to integrate geriatrics with novel basic, clinical, or health services diabetes research. This award supports pilot and feasibility studies that may lack preliminary data, but offer considerable promise for the cure, prevention, or treatment of diabetes in an aging population.
Support: Awards are a maximum of $75,000 per year for up to two years. No indirect costs may be requested.
Deadline Dates: July 15, 2008 for January 1, 2009 funding and January 15, 2009 for July 1, 2009 funding.

Call the American Diabetes Association at 1-800-DIABETES (1-800-342-2383). Our hours of operation are Monday - Friday, 8:30 AM - 8 PM Eastern Standard Time.
Or write to us:
American Diabetes Association
ATTN: National Call Center
1701 North Beauregard Street
Alexandria, VA 22311

Allied Health Professional, Behavioral Scientist, Clinical Pharmacist, Junior Faculty, Junior Investigator, Junior Researcher, Junior Scientist, New Investigator, Physician Researcher, Public Health Expert, Public Health Worker, Young Investigator, Young Scientist, Social Scientist, Health Services Researcher
Research Award in the Etiology or Pathophysiology of Diabetes
American Diabetes Association
All Regions
01/15/2009
$300,000

Research Award
Award Description: These awards provide grant support to both new and established investigators. Applications will be considered in any area that is relevant to the etiology or pathophysiology of diabetes and its complications.
Support: Awards are up to $100,000 per year for up to three years. Up to 20% of total costs for PI salary support and up to 15% for indirect costs may be requested.
Deadline Dates: July 15, 2008 for January 1, 2009 funding and January 15, 2009 for July 1, 2009 funding.

Call the American Diabetes Association at 1-800-DIABETES (1-800-342-2383). Our hours of operation are Monday - Friday, 8:30 AM - 8 PM Eastern Standard Time.
Or write to us:
American Diabetes Association
ATTN: National Call Center
1701 North Beauregard Street
Alexandria, VA 22311

Distinguished Investigator, Distinguished Scholar, Distinguished Scientist, Endocrinologist, Established Investigator, Junior Faculty, Junior Investigator, Junior Researcher, Junior Scientist, Laboratory Director, Medical School Faculty, New Investigator, Physician Researcher, Young Investigator, Young Scientist
Mentor-Based Minority Postdoctoral Fellowship
American Diabetes Association
All Regions
01/15/2009
$135,000

Mentor-Based Minority Postdoctoral Fellowship
Award Description: These awards support minority postdoctoral fellows working with established diabetes investigators. Applications must be initiated and completed by the mentor. Eligible minorities include: African American, Spanish, Hispanic or Latino, American Indian or Alaskan Native, and Native Hawaiian or Pacific Islander. The applying fellow must be a US citizen or permanent resident.
Support: Awards are $45,000 per year for up to 3 yrs. No indirect costs may be requested.
Deadline Date: January 15, 2009 for July 1, 2009 funding. Please note: January funding is not available for this award.

Call the American Diabetes Association at 1-800-DIABETES (1-800-342-2383). Our hours of operation are Monday - Friday, 8:30 AM - 8 PM Eastern Standard Time.
Or write to us:
American Diabetes Association
ATTN: National Call Center
1701 North Beauregard Street
Alexandria, VA 22311

African-American, Asian-American, Distinguished Investigator, Distinguished Scholar, Distinguished Scientist, Endocrinologist, Established Investigator, Latino/Hispanic, Medical School Faculty, Minority Member, Minority Scientist, Native American, Pharmacy Faculty, Physician Researcher, Senior Researcher

2next